Fig. 3From: Reducing travel-related SARS-CoV-2 transmission with layered mitigation measures: symptom monitoring, quarantine, and testingReductions in SARS-CoV-2 transmission during travel. a Reduction in transmission risk during a 1-day trip assuming a 7-day exposure window prior to travel, stratified by method of risk reduction. Individuals developing symptoms are assumed to be isolated and therefore do not travel. b Reductions in transmission risk during a 1-day trip assuming a 7-day exposure window prior to travel comparing the antigen assays with 80% and 95% sensitivity. Ranges indicate uncertainty from the different infectiousness modelsBack to article page